Diclofenac mediated derangement of neuroblastoma cell lipidomic profiles is accompanied by increased phosphatidylcholine biosynthesis.
D004008:Diclofenac / Q000494:pharmacology*; D004075:Diglycerides / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects*; D009447:Neuroblastoma / Q000378:metabolism*; D010713:Phosphatidylcholines / Q000096:biosynthesis*; D010716:Phosphatidylinositols / Q000378:metabolism; D010718:Phosphatidylserines / Q000378:metabolism; D064801:Phospholipase A2 Inhibitors; D054467:Phospholipases A2 / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D004075:Diglycerides; D010713:Phosphatidylcholines; D010716:Phosphatidylinositols; D010718:Phosphatidylserines; D064801:Phospholipase A2 Inhibitors; D004008:Diclofenac; D054467:Phospholipases A2